News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
72,267 Results
Type
Article (1946)
Company Profile (2)
Press Release (70319)
Section
Business (21512)
Career Advice (9)
Deals (4561)
Drug Delivery (1)
Drug Development (8169)
FDA (1813)
Job Trends (809)
News (37115)
Policy (3583)
Tag
Academia (95)
Accelerated approval (2)
Allergies (15)
Alliances (8176)
ALS (12)
Alzheimer's disease (156)
Antibody-drug conjugate (ADC) (63)
Approvals (1924)
Artificial intelligence (25)
Autoimmune disease (11)
Automation (1)
Bankruptcy (8)
Best Places to Work (593)
Biosimilars (63)
Biotechnology (5)
Bladder cancer (26)
Brain cancer (5)
Breast cancer (53)
Cancer (489)
Cardiovascular disease (16)
Career advice (9)
CAR-T (12)
Cell therapy (47)
Cervical cancer (3)
Clinical research (7441)
Collaboration (244)
Compensation (17)
Complete response letters (5)
COVID-19 (194)
C-suite (64)
Cystic fibrosis (6)
Data (585)
Depression (11)
Diabetes (31)
Diagnostics (621)
Digital health (4)
Drug discovery (33)
Drug pricing (1)
Drug shortages (1)
Duchenne muscular dystrophy (29)
Earnings (7941)
Events (7359)
Executive appointments (60)
FDA (2201)
Fibrodysplasia Ossificans Progressiva (1)
Funding (118)
Gene editing (5)
Generative AI (1)
Gene therapy (29)
GLP-1 (67)
Government (237)
Grass and pollen (1)
Guidances (39)
Healthcare (1082)
HIV (1)
Huntington's disease (2)
IgA nephropathy (18)
Immunology and inflammation (5)
Immuno-oncology (4)
Indications (12)
Infectious disease (208)
Inflammatory bowel disease (23)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (32)
IPO (1639)
Job creations (245)
Job search strategy (9)
JPM (3)
Layoffs (6)
Legal (966)
Liver cancer (18)
Lung cancer (92)
Lymphoma (36)
Manufacturing (87)
MASH (12)
Medical device (1160)
Medtech (1167)
Mergers & acquisitions (3084)
Metabolic disorders (74)
Multiple sclerosis (16)
NASH (1)
Neurodegenerative disease (25)
Neuropsychiatric disorders (5)
Neuroscience (265)
NextGen: Class of 2026 (219)
Non-profit (63)
Obesity (27)
Opinion (2)
Ovarian cancer (21)
Pain (11)
Pancreatic cancer (15)
Parkinson's disease (32)
Partnered (3)
Patents (51)
Patient recruitment (47)
Peanut (1)
People (5125)
Pharmaceutical (2)
Pharmacy benefit managers (4)
Phase 1 (2007)
Phase 2 (3131)
Phase 3 (2824)
Pipeline (574)
Policy (1)
Postmarket research (241)
Preclinical (692)
Press Release (2)
Prostate cancer (20)
Radiopharmaceuticals (22)
Rare diseases (61)
Real estate (608)
Regulatory (2878)
Reports (6)
Research institute (98)
RNA editing (2)
RSV (2)
Schizophrenia (16)
Series A (23)
Series B (21)
Service/supplier (1)
Sickle cell disease (6)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (423)
Stomach cancer (1)
Supply chain (12)
Vaccines (39)
Venture capital (5)
Weight loss (7)
Women's health (4)
Date
Last 7 days (52)
Last 30 days (209)
Last 365 days (2745)
2026 (290)
2025 (2700)
2024 (3268)
2023 (3823)
2022 (7045)
2021 (6391)
2020 (5890)
2019 (3876)
2018 (3023)
2017 (3567)
2016 (3179)
2015 (4039)
2014 (3033)
2013 (2605)
2012 (2781)
2011 (2907)
2010 (2671)
Location
Africa (88)
Alabama (3)
Arizona (11)
Asia (21999)
Australia (2467)
California (638)
Canada (372)
China (366)
Colorado (5)
Connecticut (21)
Delaware (6)
Europe (13074)
Florida (68)
Georgia (13)
Illinois (30)
India (39)
Indiana (13)
Japan (240)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (103)
Massachusetts (483)
Michigan (7)
Minnesota (34)
Missouri (3)
Nebraska (2)
Nevada (9)
New Hampshire (1)
New Jersey (388)
New York (225)
North Carolina (90)
Northern California (272)
Ohio (3)
Oregon (1)
Pennsylvania (108)
Rhode Island (1)
South America (108)
Southern California (299)
Tennessee (1)
Texas (52)
United States (2400)
Utah (24)
Virginia (44)
Washington D.C. (3)
Washington State (47)
Wisconsin (7)
72,267 Results for "lupin ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lupin Launches Dasatinib Tablets in the United States
February 2, 2026
·
2 min read
Press Releases
Lupin Launches Topiramate Extended-Release Capsules in the United States
February 5, 2026
·
2 min read
Press Releases
Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform
October 9, 2025
·
3 min read
Press Releases
Lupin Announces Presentation of Phase 1 Data on LNP3693 (STING agonist) at the ESMO Congress 2025
October 13, 2025
·
3 min read
Press Releases
Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital
September 29, 2025
·
5 min read
Press Releases
Lupin Announces Plans to Build a New State-of-the-Art Manufacturing Facility in Coral Springs, Florida Extending its Long-Standing Commitment to America’s Patients and Healthcare System
October 9, 2025
·
3 min read
Press Releases
Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi’s Long-Acting Injectable Platform
September 11, 2025
·
3 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Press Releases
QureBio Ltd. to Present at ASCO 2026 its Q-1802 Phase II Clinical Results
January 29, 2026
·
3 min read
Press Releases
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
October 1, 2024
·
5 min read
1 of 7,227
Next
